# Brexpiprazole in Alcohol Use Disorder

> **NCT04066192** · PHASE2 · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 250 (estimated)

## Conditions studied

- Alcohol Use Disorder

## Interventions

- **DRUG:** Brexpiprazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04066192
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-30
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04066192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04066192, "Brexpiprazole in Alcohol Use Disorder". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04066192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*